Kwality Pharmaceuticals Share Price

BSE
1093
+64.25 (6.13%)
KPL • 16 Jun, 2025 | 03:30 PM
BUY

1Y Annualised Return

98.28%

3Y Annualised Return

47.11%

5Y Annualised Return

100.40%

The current prices are delayed, login or Open Demat Account for live prices.

Kwality Pharmaceuticals SIP Return Calculator

Over the past

1 year
3 years
5 years

Total Investment of ₹65,00,000

Would have become ₹1,10,66,682 (+70.26%)

Daily SIP of 25,000 would have become 1,10,66,682 in 1 year with a gain of 45,66,682 (+70.26%)

Kwality Pharmaceuticals Stock Performance
Today’s Low - High
1,033.15
1,140.00
1,033.15
1,140.00
52 Week Low - High
481.00
1,140.00
481.00
1,140.00

Open

1,038.90

Prev. Close

1,028.75

Volume

1,27,451.00

Total Traded Value

13.85 Cr

View details of Market Depth
Kwality Pharmaceuticals Fundamental

Market Cap (in crs)

1,127.74

Face Value

10

Turnover (in lacs)

1,385.20

Key Metrics
Qtr Change %
New 52W High today
60.3
Dividend yield 1yr %
0

Kwality Pharmaceuticals Key Financials

View more

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

Kwality Pharmaceuticals Quarterly Revenue

Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024
115.68 Cr
84.41 Cr
90.03 Cr
80.08 Cr
91.98 Cr

Kwality Pharmaceuticals Yearly Revenue

Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
372.12 Cr
309 Cr
253.97 Cr
459.7 Cr
263.6 Cr
142.96 Cr

Kwality Pharmaceuticals Quarterly Net Profit/Loss

Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024
14.48 Cr
8.52 Cr
8.46 Cr
8.35 Cr
4.24 Cr

Kwality Pharmaceuticals Yearly Net Profit/Loss

Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
39.8 Cr
23.62 Cr
19.28 Cr
119.94 Cr
14.89 Cr
8.21 Cr

Kwality Pharmaceuticals shareholding Pattern

Promoter
54.8%
Domestic Institutions
0.3%
Public
44.9%
Promoter
54.8%
Public
45.1%
Promoter
54.8%
Public
45.2%
Promoter
54.8%
Public
45.2%
Promoter
54.8%
Public
45.2%
Promoter
54.8%
Public
45.2%

Kwality Pharmaceuticals Technical Analysis

Moving Averages Analysis
Moving Averages Analysis
1093
Current Price
Bullish Moving Averages
16
Bearish Moving Averages
0
5Day EMA
1,025.50
10Day EMA
990.20
12Day EMA
979.80
20Day EMA
945.40
26Day EMA
925.00
50Day EMA
874.20
100Day EMA
835.00
200Day EMA
782.80
5Day SMA
1,021.90
10Day SMA
976.20
20Day SMA
955.40
30Day SMA
888.00
50Day SMA
848.90
100Day SMA
801.30
150Day SMA
833.30
200Day SMA
824.60
Delivery & Volume

Delivery & Volume

PeriodCombined Delivery VolumeNSE+BSE Traded Volume
Day Rs
57601 Rs
127451 Rs
Week Rs
28591 Rs
64046 Rs
Month Rs
19919 Rs
39615 Rs
Resistance & Support
1,086.67
Pivot
Resistance
First Resistance
1,140.18
Second Resistance
1,193.52
Third Resistance
1,247.03
Support
First Support
1,033.33
Second support
979.82
Third Support
926.48
Relative Strength Index
75.72
Money Flow Index
76.06
MACD
54.80
MACD Signal
45.19
Average True Range
58.39
Average Directional Index
30.06
Rate of Change (21)
34.34
Rate of Change (125)
24.83

Kwality Pharmaceuticals Latest News

05 JUN 2025 | Thursday

Kwality Pharmaceuticals Ltd - 539997 - Announcement under Regulation 30 (LODR)-Investor Presentation

27 MAY 2025 | Tuesday

Kwality Pharmaceuticals Ltd - 539997 - Announcement under Regulation 30 (LODR)-Newspaper Publication

19 MAY 2025 | Monday

Kwality Pharmaceuticals Ltd - 539997 - Audited Standalone And Consolidated Financial Results For The Quarter And Financial Year Ended 31St March, 2025

View More

Kwality Pharmaceuticals Company background

Founded in: 1983
Managing director: Ramesh Arora
Kwality Pharmaceuticals Limited was Incorporated on May 4th 1983 when its founder Mr. Ramesh Arora was inspired to begin his own venture leaving behind the already flourishing family business of spinning and aromatics. With little background of finished pharmaceuticals and high held spirits and will, he started this business. He received his first drug license in 1981 approved for liquid oral manufacturing. Presently, the Company has 48 different sections available at their production centres.Kwality Pharmaceuticals Ltd. are manufacturer of finished pharmaceutical formulations in a Liquid Orals, Dry Syrups, Tablets, Capsules, Sterile Powder for Injections and small volume injectables. The Company has the most modern sophisticated Plant, Equipment, technique, and workforce. Certified as ISO: 9001:2015 and ISO 14001:2015, it is working with new SCHEDULE M and WHO norms and certified with GMP. The Company is keeping all records of inputs used in manufacturing. The inputs are tested as per standard laid down by company SOP. The inprocess testing records are also maintained as per SOP. Similarly, finished goods are also tested as per SOP and are then allowed for sale. Apart from these, the Company is making medicines in various dosage forms like Liquid Orals, Powder for Oral Suspension, Tablets, Capsules, Dry Syrup, Syrup, Sterile Powder for Injections, small volume injectables, Ointments, External Preparations, ORS and many more in various categories like Beta Lactam nonBeta Lactam, Hormones, Cytotoxic (Oncology) and Effervescent as per new GMP norms. Besides, it manufacture the latest drugs for the management of viral infections/diseases in different dosage forms. Each category of product is processed in a separate section, which is equipped with the latest machinery. All sections are supported by a centralized quality control department which has different segments. Each segment is equipped with the latest scientific machinery, ingredients, and trained staff supported by SOP. These segments are instrumental testing, chemical testing, pyrogen testing, and Bacterial endotoxin testing and microbiology, etc.The Company had put up a multistoried factory building in Nag Kalan, Amritsar, which started its production in March 2006. The new factory was as per WHO GMP norms. It put up the Jassur Plant in Himachal Pradesh. This unit was in the TAXfree zone, which has helped the Company to sell its Products into the Indian retail market. Kwality Pharmaceuticals, as an exporting company has supplied Remdesivir Injection to the global market and similarly Propofol injection was short in supply in various high profile countries who normally accept US FDA companies products. But in shortage of medicine, they procured these injections from the Company and after seeing the performance and efficacy, they registered the product. They started procuring the other items of the Company and it became world recognized and now the booking grew which has yielded more sales and profit for the Company.

As of 16 Jun, 2025, Kwality Pharmaceuticals share price is ₹1086.8. The stock opened at ₹1038.9 and had closed at ₹1028.8 the previous day. During today’s trading session, Kwality Pharmaceuticals share price moved between ₹1,033.15 and ₹1,140.00, with an average price for the day of ₹1.00. Over the last 52 weeks, the stock has recorded a low of ₹481.00 and a high of ₹1,140.00. In terms of performance, Kwality Pharmaceuticals share price has increased by 29.6% over the past six months and has increased by 98.28% over the last year.

Read More

Kwality Pharmaceuticals FAQs

You can easily buy Kwality Pharmaceuticals shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

Please be aware that Kwality Pharmaceuticals stock prices are subject to continuous fluctuations due to various factors.

Open Demat Account
+91 -

Open Demat Account
+91 -